Follicle-stimulating hormone polypeptide modified nanoparticle drug delivery system in the treatment of lymphatic metastasis during ovarian carcinoma therapy

Gynecologic Oncology

Volumn 135, Issue 1, 2014, Pages 125-132

  Fan, Lingling ^a   Chen, Jun ^a   Zhang, Xiaoyan ^a   Liu, Yingtao ^a   Xu, Congjian ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Follicle stimulating hormone receptor (FSHR); Follicle stimulating hormone polypeptide (FSHP); Lymphatic metastasis; Ovarian carcinoma Paclitaxel (PTX)

Indexed keywords

ESCULIN; FOLLICLE STIMULATING HORMONE POLYPEPTIDE; FOLLITROPIN; FOLLITROPIN RECEPTOR; MACROGOL; NANOPARTICLE; PACLITAXEL; UNCLASSIFIED DRUG; DRUG CARRIER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG TARGETING; DRUG UPTAKE; FEMALE; LYMPH NODE METASTASIS; NONHUMAN; OVARY CARCINOMA; RAT; HUMAN; OVARIAN NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; DRUG CARRIERS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LYMPHATIC METASTASIS; NANOPARTICLES; OVARIAN NEOPLASMS;

EID: 84908018802     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.06.030     Document Type: Article

References (23)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 1 2013 11 30
2. P. Morice, F. Joulie, S. Camatte, D. Atallah, R. Rouzier, and P. Pautier Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications J Am Coll Surg 197 2 2003 198 205
3. G. Balbi, M.A. Manganaro, A. Monteverde, I. Landino, C. Franzese, and F. Gioia Ovarian cancer: lymph node metastases Eur J Gynaecol Oncol 30 3 2009 289 291
4. P. Harter, K. Gnauert, R. Hils, T.G. Lehmann, A. Fisseler-Eckhoff, and A. Traut Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer Int J Gynecol Cancer 17 6 2007 1238 1244
5. E. Burghardt, F. Girardi, M. Lahousen, K. Tamussino, and H. Stettner Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer Gynecol Oncol 40 2 1991 103 106
6. E.K. Park, S.B. Lee, and Y.M. Lee Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs Biomaterials 26 9 2005 1053 1061
7. C.M. Keck, and R.H. Muller Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems Eur J Pharm Biopharm 84 3 2013 445 448
8. N.Z. Knezevic, and V.S. Lin A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug nanoscale 5 4 2013 1544 1551
9. P.J. Stevens, M. Sekido, and R.J. Lee A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug Pharm Res 21 12 2004 2153 2157
10. J. Wu, Q. Liu, and R.J. Lee A folate receptor-targeted liposomal formulation for paclitaxel Int J Pharm 316 1-2 2006 148 153
11. C.P. Leamon, and J.A. Reddy Folate-targeted chemotherapy Adv Drug Deliv Rev 56 8 2004 1127 1141
12. A. Gabizon, A.T. Horowitz, D. Goren, D. Tzemach, H. Shmeeda, and S. Zalipsky In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice Clin Cancer Res 9 17 2003 6551 6559
13. X. Gao, W. Tao, W. Lu, Q. Zhang, Y. Zhang, and X. Jiang Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration Biomaterials 27 18 2006 3482 3490
14. K.T., T. Minegishi, and T. Hirakawa Expression of gonadotropin and active receptor messenger ribonucleic acid in human ovarian epithelial neoplasms Clin Cancer Res 6 7 2000
15. W. Zheng, J.J. Lu, F. Luo, Y. Zheng, Y. Feng, and J.C. Felix Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone Gynecol Oncol 76 1 2000 80 88
16. C.J. Zhang XY, and Y.F. Zheng Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo Cancer Res 69 16 2009 6506 6514
17. C.J., C. Dong, and X.Y. Zhang Follicle stimulating hormone receptor mediated gene delivery to target ovarian carcinoma in vitro Asian Biomed (Res Rev News) 6 2 2012 185 194
18. R.K. Kulkarni, K.C. Pani, C. Neuman, and F. Leonard Polylactic acid for surgical implants Arch Surg 93 5 1966 839 843
19. H. Lu, B. Li, Y. Kang, W. Jiang, Q. Huang, and Q. Chen Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting Cancer Chemother Pharmacol 59 2 2007 175 181
20. D.V. Parrott JA, and G. Kim Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer Mol Cell Endocrinol 172 1-2 2001 213 222
21. X.Y. Zhang, J. Chen, Y.F. Zheng, X.L. Gao, Y. Kang, and J.C. Liu Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo Cancer Res 69 16 2009 6506 6514
22. J. Panyam, S.K. Sahoo, S. Prabha, T. Bargar, and V. Labhasetwar Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d,l-lactide-co-glycolide) nanoparticles Int J Pharm 262 1-2 2003 1 11
23. J. Guo, X. Gao, L. Su, H. Xia, G. Gu, and Z. Pang Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery Biomaterials 32 31 2011 8010 8020